TABLE 3.
Sons’ Beliefs in Sexual Disinhibition After HPV Vaccination (n = 176)
| n (%) | Mean Beliefs in Sexual Disinhibition (SD) |
Bivariate, β |
Multivariate, β |
|
|---|---|---|---|---|
| Son characteristics | ||||
| Age, y* | ||||
| 15 | 41 (23) | 2.89 (0.94) | −0.01 | — |
| 16 | 62 (35) | 2.92 (0.86) | Ref | — |
| 17 | 73 (41) | 2.62 (0.99) | −0.16 | — |
| Race/Ethnicity* | ||||
| White, non-Hispanic | 116 (66) | 2.79 (0.92) | 0.14 | 0.13 |
| African American, non-Hispanic | 23 (13) | 2.52 (0.91) | Ref | Ref |
| Hispanic | 28 (16) | 3.09 (1.03) | 0.22† | 0.21† |
| Other | 9 (5) | 2.56 (0.85) | 0.01 | 0.01 |
| Seen regular health care provider in last year* | ||||
| No | 49 (28) | 2.83 (0.92) | Ref | — |
| Yes | 127 (72) | 2.78 (0.95) | −0.02 | — |
| Self-rated health‡,§ | 3.91 (0.91) | N/A | −0.10 | — |
| Received any doses of HPV vaccine* | ||||
| No | 171 (97) | 2.79 (0.94) | Ref | — |
| Yes | 5 (3) | 2.70 (1.10) | −0.02 | — |
| Household characteristics | ||||
| Urbanicity | ||||
| Rural | 31 (18) | 2.98 (0.94) | Ref | — |
| Urban | 145 (82) | 2.75 (0.94) | −0.10 | — |
| Region of residence | ||||
| South | 54 (31) | 2.61 (1.01) | Ref | — |
| Northeast | 39 (22) | 2.82 (1.10) | 0.09 | — |
| Midwest | 50 (28) | 2.89 (0.70) | 0.13 | — |
| West | 33 (19) | 2.89 (0.95) | 0.12 | — |
| HPV and HPV vaccine | ||||
| Knowledge about HPV | ||||
| Never heard of HPV before survey | 105 (60) | 2.81 (0.87) | Ref | — |
| Heard of HPV, low knowledge | 27 (15) | 2.78 (1.03) | −0.01 | — |
| Heard of HPV, high knowledge | 44 (25) | 2.74 (1.06) | −0.04 | — |
| Perceived likelihood of getting HPV-related disease‡,¶ | 2.09 (0.65) | N/A | 0.17† | 0.11 |
| Has a sister who has received HPV vaccine* | ||||
| No | 65 (37) | 2.73 (1.04) | Ref | — |
| Yes | 31 (18) | 2.89 (0.67) | 0.06 | — |
| Does not have a sister | 80 (45) | 2.80 (0.95) | 0.04 | — |
| Comfort talking with parents about new vaccines‡,‖ | 3.66 (1.11) | N/A | −0.05 | — |
| Amount talked with parents about HPV vaccine‡,** | 1.16 (0.46) | N/A | −0.04 | — |
| Perceived knowledge about HPV vaccine‡,†† | 1.39 (0.66) | N/A | −0.11 | — |
| Perceived peer acceptance of HPV vaccine‡,‡‡ | 3.06 (0.59) | N/A | 0.46§§ | 0.44§§ |
| Potential embarrassment of getting HPV vaccine‡,¶¶ | 2.84 (1.02) | N/A | 0.10 | — |
| Anticipated regret if got HPV vaccine and fainted‡,** | 2.59 (1.10) | N/A | −0.11 | — |
| Anticipated regret if didn’t get HPV vaccine and later got HPV infection‡,** | 3.16 (0.94) | N/A | 0.09 | — |
Sexual disinhibition was measured using 2 items (α = 0.83) that each had a 5-point response scale ranging from “strongly disagree” to “strongly agree” (coded 1–5). β represents standardized regression coefficients. Multivariate model did not include variables with dashes (—).
Data collected during parent survey.
P < 0.05.
Continuous variable with overall mean (SD) reported.
Five-point response scale ranging from “poor” to “excellent” (coded 1–5).
Four-point response scale ranging from “no chance” to “high chance” (coded 1–4).
Two-item scale; each item had a 5-point response scale ranging from “very uncomfortable” to “very comfortable” (coded 1–5).
Four-point response scale ranging from “not at all” to “a lot” (coded 1–4).
Four-point response scale ranging from “nothing at all” to “a lot” (coded 1–4).
Four-item scale; each item had a 5-point response scale ranging from “strongly disagree” to “strongly agree” (coded 1–5).
P < 0.001.
Two-item scale; each item had a 5-point response scale ranging from “strongly disagree” to “strongly agree” (coded 1–5).
Ref indicates referent group; N/A, not applicable due to variable being continuous.